Ledger.Open graph →
SEC Form D · filed October 8, 2019

CerSci Therapeutics Inc

Offering
$8.0M
Sold
$8.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DALLAS, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Lucas Rodriguez · Dallas, TXDirectorBrent Duncan · Lewisville, TXDirectorGeorge Schaeffer · San Francisco, CADirectorTyler Brous · Dallas, TXDirectorScott Dax · Landenberg, PADirectorDavid Genecov · Dallas, TXDirectorDavid Hitt Ii · Plano, TXDirectorDennis Robbins · Richardson, TXDirectorPat Confalone · Wilmington, DEDirectorJohn D. Harkey, Jr · Dallas, TXDirectorPerry Molinoff · Exton, PADirectorVinay Nair · Boulder, CODirectorTyler Brous · Dallas, TXDirectorScott Dax · Landenberg, PADirectorDavid Genecov · Dallas, TXDirectorDavid Hitt Ii · Plano, TXDirectorDennis Robbins · Richardson, TXDirectorPat Confalone · Wilmington, DEDirectorBrent Duncan · Lewisville, TXDirectorJohn D. Harkey, Jr · Dallas, TXDirectorPerry Molinoff · Johns Island, SCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗